Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin.
about
Genotyping of hepatitis C virus isolates from Basque Country, SpainProvision of syringes: the cutting edge of harm reduction in prison?Hepatitis C: an epidemiological review.A multicentre sero-behavioural survey for hepatitis B and C, HIV and HTLV among people who inject drugs in Germany using respondent driven samplingSeroprevalence of hepatitis C markers among intravenous drug users in western European countries: a systematic review.Hepatitis C and HIV co-infection: a reviewHigh variability of HIV and HCV seroprevalence and risk behaviours among people who inject drugs: results from a cross-sectional study using respondent-driven sampling in eight German cities (2011-14).A systematic review of hepatitis C virus epidemiology in Europe, Canada and Israel.Characteristics and prospects for hepatitis C therapy of an HIV-HCV coinfected population followed at a reference HIV center.Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil.Distribution of HCV genotypes among different exposure categories in Brazil.Human immunodeficiency virus seroprevalence among inmates of the penitentiary complex of the region of campinas, state of São Paulo, Brazil.Research of antigen and antibodies from retroviruses, CMV and HBV among prisoners of the penitentiary complex of the region of Campinas, SP, Brazil.
P2860
Q27485608-2CFDFAF1-66E7-4CFA-8B44-9A711148DEA4Q33791199-458BAFA1-9464-4224-BEB2-4440D390444AQ34551348-9C9A3954-0453-4BB3-8541-04C2A11E8554Q34584310-A6DEC9E7-892C-4507-9F90-95889C305A6AQ34637206-5E6F03AB-97A4-4282-A5EA-27D6F9E6304EQ34782891-BC157D0C-A5D5-4ADE-B7ED-19DA01AE3561Q36123087-F88DF016-0B76-4771-80BF-34ED232FFCAAQ37886280-69AAC694-675B-4A9E-BE6E-2334B7CD1104Q40353664-3DF50264-9A9D-4EED-BCC7-2AD14290C8FAQ42608699-4A12B448-B97A-4739-8077-1B6F40EB803FQ42993720-5073F2B4-02D6-4588-A2FC-A7A15BB811ADQ45747847-328B0C91-C26C-4EC9-824C-7BD9309F01AAQ55240177-ED8C908C-65C2-49DF-B960-CB68A583F1DF
P2860
Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年学术文章
@wuu
1995年学术文章
@zh
1995年学术文章
@zh-cn
1995年学术文章
@zh-hans
1995年学术文章
@zh-my
1995年学术文章
@zh-sg
1995年學術文章
@yue
1995年學術文章
@zh-hant
name
Prevalence and determinants of ...... ravenous drug users in Berlin.
@en
Prevalence and determinants of ...... ravenous drug users in Berlin.
@nl
type
label
Prevalence and determinants of ...... ravenous drug users in Berlin.
@en
Prevalence and determinants of ...... ravenous drug users in Berlin.
@nl
prefLabel
Prevalence and determinants of ...... ravenous drug users in Berlin.
@en
Prevalence and determinants of ...... ravenous drug users in Berlin.
@nl
P2093
P2860
P1476
Prevalence and determinants of ...... ravenous drug users in Berlin.
@en
P2093
P2860
P304
P356
10.3109/00365549509032726
P577
1995-01-01T00:00:00Z